ASML vs BBAI

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score and negative profitability metrics raise concerns. Despite strong liquidity (Current Ratio: 3.13), the company is deeply unprofitable with a -295.61% profit margin and -120.34% ROE, while revenue is declining YoY by -20.10%. Valuation multiples are extremely stretched with a Price/Sales of 18.48 and a negative Forward P/E of -29.10, suggesting speculative pricing unsupported by fundamentals. Insider selling and weak earnings surprise history further undermine confidence.